-+ 0.00%
-+ 0.00%
-+ 0.00%

Caris Life Sciences launches USD 100 million share buyback program

PUBT·06/08/2026 12:31:47
Listen to the news
Caris Life Sciences launches USD 100 million share buyback program
  • Caris Life Sciences launched a share repurchase program of up to USD 100 million for its outstanding common stock.
  • Buybacks may be executed in the open market or via privately negotiated transactions, including Rule 10b5-1 trading plans.
  • The program has no expiration date. It can be modified, suspended, or ended at the board’s discretion.
  • Repurchases are expected to be funded from available cash and cash equivalents.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DA77870) on June 08, 2026, and is solely responsible for the information contained therein.